电脑桌面
添加小米粒文库到电脑桌面
安装后可以在桌面快捷访问

数图药讯2012年第18期VIP免费

数图药讯2012年第18期_第1页
1/21
数图药讯2012年第18期_第2页
2/21
数图药讯2012年第18期_第3页
3/21
2012年6月1日第18期总第379期—出版—中国医药工业信息中心审阅:祝林编写:邵雯君美编:钱苗苗地址:上海市北京西路1320号邮编:200040电话:021-62477965传真:021-62890581信息来源:www.pharmadl.com中国医药数字图书馆感谢您一贯的支持!掌握医药界的众多变化,请继续关注我们给您带来的精彩及时的药讯快报!目录新药上市...................................................................................1FDA批准Stendra用于男性勃起功能障碍·················································1FDA授予Andromeda公司糖尿病药物DiaPep277罕用药地位···············2Mylan在美推出立普妥仿制药····································································2Sun医药公司Azelastine鼻用喷雾仿制药获美FDA批准·······················3审批进展...................................................................................3FDA顾问委员会推荐批准新款减肥药罗卡西林·······································3EMA建议批准新型囊性纤维化药物Kalydeco··········································4西班牙Almirall公司COPD药物aclidinium获EMA肯定意见·············5卫材癫痫新药Fycompa获CHMP积极意见··············································5辉瑞Axitinib作为晚期肾癌二线治疗获CHMP肯定意见······················6诺和诺德重组凝血因子XIII获欧盟积极意见···········································7强生HIV药物Prezista高剂量版本上市审批申请遭FDA拒绝·············7利伐沙班用于ACS未通过FDA顾问委员会审评·····································7业界动态...................................................................................8世卫组织:全球非传染性疾病负担日益严重············································8礼来、诺和诺德、赛诺菲激战糖尿病药物市场········································9行业分析.................................................................................10药用明胶原料价格上涨20%医药行业面临成本压力······························10国际仿制药企业Teva、Mylan、Ranbaxy的分析比较·····························12中药注射剂:重拾信任要靠产业升级·······················································14本周视点.................................................................................16中医药“十二五”规划出炉·······································································16专利详解.................................................................................18Trimegestone主要相关专利········································································18数图药讯中国医药工业信息中心1新药上市FDA批准Stendra用于男性勃起功能障碍年4月27日,FDA批准治疗男性勃起功能障碍新药avanafil(Stendra)。美国大约有3千万男性受到勃起功能障碍困扰。患者可在在性行为前30分钟按需服用Stendra。医生应按最低的...

1、当您付费下载文档后,您只拥有了使用权限,并不意味着购买了版权,文档只能用于自身使用,不得用于其他商业用途(如 [转卖]进行直接盈利或[编辑后售卖]进行间接盈利)。
2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。
3、如文档内容存在违规,或者侵犯商业秘密、侵犯著作权等,请点击“违规举报”。

碎片内容

数图药讯2012年第18期

确认删除?
VIP
微信客服
  • 扫码咨询
会员Q群
  • 会员专属群点击这里加入QQ群
客服邮箱
回到顶部